All filters
E-Posters
Feasibility and Acceptability of a Peer Youth LED Curriculum to Improve HIV Knowledge in Northern Tanzania: Resilience and Intervention Experience From the Perspective of Peer Leaders
K. Hosaka
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Trends in HIV Self-Testing Among Adolescent and Youth Populations Across Sub-Saharan Africa
M. Ethridge
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Lopinavir Drug Exposures in African Children With HIV Using Lopinavir/Ritonavir Pellets Dosed per Who Weight-Bands
S. Chupradit
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Abacavir Weight-Band Dosing For Infants in the First 4 Weeks of Life
T. Cressey
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Exposure to Two Dolutegravir Formulations in Children in the Odyssey Trial
H. Waalewijn
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Assessing Parental Choice of Lopinavir/Ritonavir Granules Intake to Improve Child Adherence at Baylor-Mwanza, Tanzania
C. Gesase
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Caregivers Perception on Paedriatic Lopinavir/Ritonavir Formulations for HIV Infected Children at Baylor Clinic, Mwanza-Tanzania
C. Gesase
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Effects of Long-Term Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/Taf) On Bone Safety Parameters in Children and Adolescents Living With HIV
N. Rakhmanina
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Effect of Dolutegravir on Folate and Vitamin b12 Status Among HIV-Infected Children and Adolescents in the Odyssey Trial
L. Barlow-Mosha
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Neuropsychiatric Manifestations and Sleep Disturbances in Children and Adolescents Randomised to Dolutegravir-Based Art vs Standard-of-Care in the Odyssey Trial
A. Violari
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Mutations Associated With Ineffectiveness of HIV-1 Protease Inhibitors in Children in Abidjan, Côte D'Ivoire
J.R. Dechi
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Early Trends in HIV Drug Resistance Mutations Among Pediatric and Young Adult (0-24 Years) Clients in Sub-Saharan Africa
S. Perry
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
HIV Drug Resistance Patterns Among Highly Treatment-Experienced Children, Adolescents and Young Adults in Sub-Saharan Africa
A. Tiam
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Successful Scale- Up of Optimal Antiretroviral Regimens and Improvement in Viral Suppression for Children and Adolescents Living With HIV Amidst COVID 19 Pandemic in Kenya
I. Mutisya
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
The Road to Success Is Paved With Dolutegravir: Dolutegravir Treatment Success Among in Children and Adolescents Living With HIV (Calhiv) At the Baylor Tanzania Centres of Excellence
J. Bacha
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Challenges in the Effective Treatment of Infant HIV Undermine the Potential Impact of Birth Testing and Neonatal Art: Preliminary Results From the Life Trial in Mozambique and Tanzania
A. Mahumane
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Adolescent and Caregiver Perspectives on an Enhanced Adherence Counseling Intervention for Youth With Suspected HIV Treatment Failure in Kenya
M. Gill
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Adherence to Antiretroviral Therapy Among Children Living With HIV in North-Central Nigeria: A Qualitative Evaluation of Barriers and Facilitators Among Caregivers
T.L. Jasper
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Viral Load Coverage and Suppression Around COVID-19: Eswatini
M. Abadie
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
The Baylor International Pediatric Aids Initiative (Bipai) Network’s Progress Towards the Second and Third Unaids 95-95-95 Goals Among Calhiv Receiving Care in Pediatric HIV Centers in Six Countries in Sub-Saharan Africa
J. Bacha
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
What Are the Drivers of Improved Viral Suppression Among HIV Infected Children (0-14 Years)? Results From the National Data Warehouse in Kenya 2020
I. Mutisya
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Low Viral Suppression Among Children < 3 Years Old on Two Protease Inhibitor Formulations in Kenya, 2015-2019
I. Mutisya
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
Intensified Technical Assistance on Multi-Month Dispensing Of Antiretroviral Therapy to Children and Adolescents Living With HIV Resulted in Achievement of the 85% Pepfar Benchmark in Nigeria
C. Casalini
Presented at:
International Workshop on HIV Pediatrics 2021
E-Posters
“I Now Always Go Out to Play”: Evaluating the Impact of the New Horizons Initiative for Third-Line HIV Treatment for Pediatric Patients in Kenya, Uganda and Zambia.
E. Durden
Presented at:
International Workshop on HIV Pediatrics 2021